A carregar...
Cardiovascular safety signals with dipeptidyl peptidase-4 inhibitors: A disproportionality analysis among high-risk patients
PURPOSE: In 2008, the US Food and Drug Administration (FDA) issued Draft Guidance on investigating cardiovascular risk with oral diabetic drugs, including dipeptidyl peptidase-4 inhibitors (DPP-4i). In 2014, underpowered, post hoc analyses of clinical trials suggested an increased risk of heart fail...
Na minha lista:
| Publicado no: | Pharmacoepidemiol Drug Saf |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6727842/ https://ncbi.nlm.nih.gov/pubmed/29655237 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.4437 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|